First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
J R KroepPeter Hohenberger

Abstract

the role of chemotherapy in advanced malignant peripheral nerve sheath tumor (MPNST) is unclear. chemotherapy-naive soft tissue sarcomas (STS) patients treated on 12 pooled nonrandomized and randomized European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials were retrospectively analyzed. Clinical outcomes, overall survival, progression-free survival (PFS) and response were determined for MPNST and other STS histotypes and compared. Additionally, prognostic factors within the MPNST population were defined. Studied cofactors were demographics, sarcoma history, disease extent and chemotherapy regimen. after a median follow-up of 4.1 years, 175 MPNST out of 2675 eligible STS patients were analyzed. Outcome was similar for MPNST versus other STS histotypes, with a response rate, median PFS and overall survival of 21% versus 22%, 17 versus 16 weeks and 48 versus 51 weeks, respectively. Performance status was an independent prognostic factor for overall survival. Chemotherapy regimen was an independent prognostic factor for response (P < 0.0001) and PFS (P = 0.009). Compared with standard first-line doxorubicin, the doxorubicin-ifosfamide regimen had the best response, whereas ifosfamide ha...Continue Reading

References

Oct 27, 1998·International Journal of Radiation Oncology, Biology, Physics·W W WongL L Gunderson
Dec 11, 1999·Science·K CichowskiT Jacks
Dec 11, 1999·Science·K S VogelL F Parada
Dec 22, 1999·Journal of Clinical Pathology·J F Graadt van RoggenP C Hogendoorn
Jul 24, 2001·Medical and Pediatric Oncology·Y Tsuchida, P Therasse
May 16, 2002·Journal of Medical Genetics·D G R EvansA Moran
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martee L HensleyDavid R Spriggs
May 8, 2003·Annals of Surgical Oncology·Jonathan B KoeaMurray F Brennan
Jul 15, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pancras C W HogendoornUNKNOWN Pathology and Biology Subcommittee of the EORTC Soft Tissue and Bone Sarcoma Group
Jan 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Stéphane BerghmansA Thomas Look
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea FerrariFranca Fossati-Bellani
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Modesto CarliJoern Treuner
May 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P G CasaliUNKNOWN ESMO Guidelines Working Group
Jul 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Alyson W MacInnesJacqueline A Lees
Sep 6, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M SchlemmerJ Y Blay

❮ Previous
Next ❯

Citations

Nov 6, 2010·Der Pathologe·D PinkP Reichardt
May 14, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N PenelUNKNOWN French Sarcoma Group (GSF/GETO)
Apr 20, 2014·Case Reports in Otolaryngology·Puja SahaiChirom Amit Singh
Jun 28, 2014·Case Reports in Pediatrics·Jong Hyung YoonByung-Kiu Park
Mar 12, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Myrella VlenterieWinette Ta van der Graaf
Sep 26, 2013·Case Reports in Oncological Medicine·Amina MohtaramHassan Errihani
Mar 19, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Arjen H G ClevenJudith V M G Bovée
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Parthasarathy SeshacharyuluSurinder K Batra
Mar 15, 2015·Indian Journal of Dentistry·Uday Shankar YagaSathyaprakash
Dec 3, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J YoungW T A van der Graaf
Jun 28, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah InghamD Gareth R Evans
Jul 18, 2014·Lancet Neurology·Angela C Hirbe, David H Gutmann
Jul 19, 2016·Clinical Neurology and Neurosurgery·Xiaotian JiaTadashi Kondo
Feb 26, 2013·Brachytherapy·Caroline L HollowayD Jeffrey Demanes
Oct 20, 2006·Auris, Nasus, Larynx·Jiung-Chih ChaoJeh-En Tzeng
Sep 4, 2016·Surgical Oncology Clinics of North America·Aaron W JamesFritz C Eilber
Oct 19, 2016·International Journal of Cancer. Journal International Du Cancer·Kunihiro IkutaYoshihiro Nishida
Apr 5, 2018·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Oliver D MrowczynskiElias B Rizk
Feb 24, 2018·Journal of Neurosurgery·Russell PayneElias B Rizk
Dec 1, 2017·Journal of Biomedical Optics·Marjorie CarlsonPaolo P Provenzano
Sep 11, 2018·Journal of Cancer Research and Therapeutics·S ShanmugasundaramB Srinivas
Feb 6, 2019·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·N A KonovalovA A Batyrov
Jul 25, 2019·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·N A KonovalovA A Batyrov
Jan 29, 2014·The Oncologist·Mohamad FaridRobert G Maki
May 8, 2020·Journal of Adolescent and Young Adult Oncology·Eugenie YoungerWinette T A van der Graaf
Nov 29, 2017·Oncotarget·Maurits de VriesPancras C W Hogendoorn
Jul 30, 2020·The Journal of Hand Surgery Asian-Pacific Volume·Chung Ming ChanMark E Puhaindran
Jun 30, 2012·Pediatric Blood & Cancer·Narendra Chaudhary, Anupama Borker
Jul 9, 2020·International Journal of Cancer. Journal International Du Cancer·Yoshihiro NishidaAkira Kawai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST)
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Salvatore RomeoEuropean Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Raf SciotAustralasian Trials Group
© 2021 Meta ULC. All rights reserved